SkinHealth Systems (SKIN) Operating Leases (2021 - 2026)

SkinHealth Systems (SKIN) has reported Operating Leases for 6 consecutive years, with $18.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Leases rose 112.22% year-over-year to $18.0 million in Q2 2026; TTM through Jun 2026 was $18.0 million, a 112.22% increase from a year earlier, with the FY2025 full-year figure at $9.2 million, down 42.12% from the prior year.
• Operating Leases was $18.0 million for Q2 2026 at SkinHealth Systems, down from $18.8 million in the prior quarter.
• Over five years, Operating Leases peaked at $18.8 million in Q1 2026 and troughed at $8.5 million in Q2 2025.
• A 5-year average of $12.8 million and a median of $12.2 million in 2023 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases slumped 42.12% in 2025 and soared 112.22% in 2026, its largest moves.
• Over 5 years, Operating Leases stood at $17.6 million in 2022, then slipped by 21.14% to $13.9 million in 2023, then grew by 14.68% to $16.0 million in 2024, then plunged by 42.12% to $9.2 million in 2025, then surged by 94.58% to $18.0 million in 2026.
• The last three Operating Leases figures came in at $18.0 million (Q2 2026), $18.8 million (Q1 2026), and $9.2 million (Q4 2025), per Business Quant data.